Can COVID-19 reach the choroid plexus?

By SWA

 

The involvement of COVID-19 (caused by the SARS-CoV-2 virus) with the choroid plexus has been an area of investigation. The choroid plexus is a structure in the brain that produces cerebrospinal fluid (CSF) and acts as a barrier between the bloodstream and the CSF, playing a role in the central nervous system's immune responses.

There are several reasons to suspect potential interactions between SARS-CoV-2 and the choroid plexus:

  1. ACE2 Expression: The main entry receptor for SARS-CoV-2, angiotensin-converting enzyme 2 (ACE2), is expressed in various tissues throughout the body, including the brain. Some studies have shown that the choroid plexus expresses ACE2, which could provide a potential entry route for the virus.

  2. Neurological Symptoms: Some COVID-19 patients exhibit neurological symptoms ranging from mild (like headaches and loss of smell) to more severe (like encephalopathy, strokes, and seizures). Understanding how the virus could access the central nervous system is vital for elucidating the underlying mechanisms of these symptoms.

  3. Post-mortem studies: Limited post-mortem studies have been performed on patients who succumbed to COVID-19. Some studies have found traces of SARS-CoV-2 RNA or proteins in the brain tissue, but the exact location and significance of these findings are still being explored.

While the potential for SARS-CoV-2 to access the choroid plexus and subsequently the central nervous system is a topic of interest, direct evidence of the virus's presence in the choroid plexus or its definitive role in causing neurological symptoms remains to be fully clarified. Further studies are needed to understand the full spectrum of the virus's interaction with the central nervous system and its associated structures.

SARS-CoV-2 Infects the Brain Choroid Plexus and Disrupts the Blood-CSF Barrier in Human Brain Organoids
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7553118/


Comments

Post a Comment

Popular posts from this blog

Toxic Skin Condition Post-mRNA COVID-19 Vaccination

By SWA
Image
Identifying Severe Skin Conditions Post-Vaccination Following administration of the BioNTech mRNA vaccine, a small subset of individuals may develop severe and complex reactions. These reactions are often misdiagnosed or misunderstood due to their rarity and diverse presentation. This essay examines a case characterized by severe skin conditions, systemic symptoms, and complications such as hypercalcemia and crystal formation. It highlights the need for accurate diagnosis, holistic management, and increased awareness of these rare but significant vaccine-related adverse events. Initial Symptoms and Misdiagnoses Severe symptoms began shortly after the first dose of the BioNTech vaccine, initially presenting as petechiae, diagnosed by a rheumatologist. However, following the second dose, symptoms rapidly escalated, resulting in intense burning pain and thinning of the skin. The skin on the legs and thighs became paper-thin and could tear with the slightest touch, with the affected area e...
Read more

Dysferlin Protein: Key Roles, Genetic Locations

By SWA
Image
The purpose of this article is to share and discuss the details of a new discovery, which is highlighted within: CRISPR-Cas9: A Breakthrough Tool to Repair the DYSF Gene The dysferlin protein plays an essential role in maintaining the integrity of muscle cell membranes, particularly in tissues that endure significant mechanical stress, such as skeletal and cardiac muscles . Encoded by the DYSF gene , dysferlin is indispensable for repairing damaged cell membranes after injury caused by muscle contraction or external forces. This article explores the main locations where dysferlin is produced, its role in muscle repair, and supportive nutritional and therapeutic strategies for individuals with dysferlin deficiency, such as those affected by dysferlinopathies (e.g., Limb-Girdle Muscular Dystrophy Type 2B or Miyoshi Myopathy). Currently, there is no definitive answer as to why the severity of dysferlin protein expression or depletion varies. Do pathogens play a role in the methylation o...
Read more

Is ME CFS connected to Spinal Muscular Atrophy (SMA) or Post Polio?

By SWA
Image
Today, I understand why Spinal Muscular Atrophy (SMA) received little attention, particularly in the mid-50s. This complex and debilitating genetic illness was poorly understood, and patients' symptoms were often minimized or even dismissed. For more information, please visit the Spinal Muscular Atrophy (SMA) page on MalaCards . Even now, many neurologists lack detailed knowledge of SMA, and comprehensive examinations mentioned in research are rarely pursued. In 2008, while investigating permanent adrenal insufficiency, an MRI ordered by my endocrinologist unexpectedly revealed Chiari Malformation II. However, surgery in 2009 brought no improvement. In 2010, a DNA test showed a genetic marker in the ACTN3 gene: https://www.malacards.org/search/results?q=ACTN3%20gene%20and%20Spinal%20Muscular%20Atrophy%20(SMA) A 2015 MRI revealed ankylosing spondylitis, multiple Tarlov cysts, stenosis at L4 and L5, spinal canal narrowing, and widespread degenerative changes. Surgery on L4 and L5 ...
Read more